About Hatchtech

Single application head lice product capable of killing both eggs and lice.


Hatchtech has an experienced board of directors with skill sets and backgrounds spanning science, finance, business development and drug development. The members of the Hatchtech board are as follows:


Latest News

Oct 21, 2014 Hatchtech Announces Successful Results from Phase 2 Ovicidal Study

Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results

Dec 11, 2013 Hatchtech Receives SPA and Announces Patent Grants

Oct 31, 2013 Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission